ALTERITY THERAPEUTICS-ADR (ATHE) Stock Income Statement
NASDAQ:ATHE - Nasdaq - US02155X2053 - ADR - Currency: USD
| TTM (2024-12-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 261.30K | 268.40K | 16.40K | 2.50K | 20.70K | |||
| Operating Expenses | 20.20M | 19.61M | 14.64M | 15.96M | 15.39M | |||
| Research and Development | 18.00M | 18.64M | 13.20M | 14.75M | 12.28M | |||
| Selling, General, and Administrative Expenses | 5.72M | 4.84M | 5.22M | 5.82M | 7.16M | |||
| Operating Income | -19.94M | -19.34M | -14.62M | -15.95M | -15.37M | |||
| Interest Income/Expense | 196.10K | 261.20K | 917.70K | 2.72M | -297.10K | |||
| Other Income/Expense | N/A | 0.00 | 2.10K | 454.10K | 213.20K | |||
| Non Recurring Items | N/A | 0.00 | 0.00 | 0.00 | 145.60K | |||
| Income Before Taxes | -19.74M | -19.08M | -13.70M | -12.78M | -15.31M | |||
| Income Tax | 46.10K | 46.10K | 104.50K | 70.00K | 0.00 | |||
| Net Income | -19.79M | -19.12M | -13.81M | -12.85M | -15.31M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.38 | -1.80 | -1.97 | -1.83 | -3.12 | |||
| Statistics | ||||||||
| Profit Margin | -7573.52% | -7125.00% | -84185.98% | -513884.00% | -73958.45% | |||
| Operating Profit Margin | -7630.92% | -7205.10% | -89157.32% | -638144.00% | -74256.52% | |||
All data in AUD